Mirum Names Rob Myers CMO as Joanne Quan Departs

Evidence Company release · Effective September 21, 2026 · Discovery September 8, 2026 · Importance 3/5 · Direction Neutral Summary Mirum Pharmaceuticals appointed Rob Myers, M.D., chief medical officer effective September 21, 2026. He succeeds Joanne Quan, M.D., who is departing; the company did not…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *